However, the cost per day in this segment increased by 3.5% year-over-year. Contessa, another segment of Amedisys, reported sluggish revenue at $8.1 million in the fourth quarter of 2024 ...

However, the cost per day in this segment increased by 3.5% year-over-year. Contessa, another segment of Amedisys, reported sluggish revenue at $8.1 million in the fourth quarter of 2024, which was a ...

Most recently, she served as President of Contessa Health, a subsidiary of Amedisys. At Contessa Health, she played a pivotal role in shaping operations, identifying and driving market expansion ...

Amedisys has a twelve month low of $82.15 and a twelve month high of $98.95. Get Amedisys alerts: Amedisys (NASDAQ:AMED – Get Free Report) last announced its quarterly earnings results on ...

Shares of NASDAQ AMED opened at $92.60 on Wednesday. The company’s 50-day simple moving average is $90.11 and its 200-day simple moving average is $93.58. Amedisys has a 52-week low of $82.15 ...

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month ...

William Blair analyst Matt Larew maintained a Hold rating on Amedisys (AMED – Research Report) today. The company’s shares closed yesterday at $91.57. See what stocks are receiving Strong Buy ...